| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in PAHC over the last quarter tilts toward buying: insiders added a net 10,000 shares worth roughly $318K.
PAHC sits in the Pharmaceuticals industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 51.5K | $1.87M | - | |
| Dir | 41.5K | $1.51M | - | |
| COO | 34.5K | $1.25M | - | |
| Other | 14.5K | $528.0K | - | |
| CEO | 3.5K | $126.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 16, 2017 | Bendheim Daniel M | Exec. VP, Corporate Strategy | Sale+OE | 7,681 | $40.04 | $307,573.67 | -100% | |
| Jul 6, 2017 | Bendheim Jack55 | President And CEO | Sell | 32,000 | $36.49 | $1,167,680.00 | -44.4% | |
| Jul 6, 2017 | Bfi Co., LLC | 10% Owner | Sell | 32,000 | $36.49 | $1,167,680.00 | -44.4% | |
| Jun 30, 2017 | Bendheim Jack55 | President And CEO | Sell | 48,000 | $37.42 | $1,796,286.00 | -16.7% | |
| Jun 30, 2017 | Bfi Co., LLC | 10% Owner | Sell | 48,000 | $37.42 | $1,796,286.00 | -16.7% | |
| Jun 23, 2017 | Bendheim Jack55 | President And CEO | Sell | 48,000 | $37.15 | $1,783,360.00 | -20.0% | |
| Jun 23, 2017 | Bfi Co., LLC | 10% Owner | Sell | 48,000 | $37.15 | $1,783,360.00 | -20.0% | |
| Jun 15, 2017 | Bendheim Jack55 | President And CEO | Sell | 48,000 | $34.82 | $1,671,518.15 | -15.8% | |
| Jun 15, 2017 | Bfi Co., LLC | 10% Owner | Sell | 48,000 | $34.82 | $1,671,518.15 | -15.8% | |
| Jun 9, 2017 | Bfi Co., LLC | 10% Owner | Sell | 48,000 | $35.62 | $1,709,920.00 | -20.0% |